🩺 Clinical / Exam Application
A COPD patient with chronically elevated CO2 levels is given high-flow supplemental oxygen for low blood oxygen, and their breathing rate unexpectedly drops further. Because chronic CO2 retention has caused this patient's central chemoreceptors to become desensitized to CO2 over time, their body has shifted to relying on LOW OXYGEN levels as the primary trigger to breathe (the "hypoxic drive") instead of the normal CO2-based trigger. Administering high-flow oxygen removes this remaining low-oxygen stimulus, paradoxically reducing their drive to breathe — a well-known, carefully managed risk in COPD patient care.